SLDB
HealthcareSolid Biosciences Inc.
$7.17-0.54 (-7.00%)
Prev Close
$7.71
Open
$7.79
High
$7.84
Low
$7.16
Volume
1.39M
Market Cap
$614.9M
P/E
—
Div Yield
—
Over the past 12 months, insider activity at Solid Biosciences Inc. (SLDB) has been exclusively selling, with 0 insider purchases totaling $0.00 and 33 insider sales totaling $2.91M. The most recent insider transaction was by Cumbo Alexander (director, officer: President and CEO), who sold $96.9K worth of shares on Feb 18, 2026. Solid Biosciences Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $614.9M.
Buys (12M)
0
$0.00
Sells (12M)
33
$2.91M
Net Activity
Net Seller
$2.91M
Active Insiders
7
last 12 mo
SLDB Price Chart
SLDB Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Feb 18, 2026↗ | Cumbo Alexander | director, officer: President and CEO | Sell | 16,644 | $5.82 | $96.9K | 235,405 |
| Feb 18, 2026↗ | Ganot Ilan | director | Sell | 2,658 | $5.82 | $15.5K | 27,474 |
| Feb 18, 2026↗ | Hanrahan Jessie | officer: Chief Regulatory Officer | Sell | 4,134 | $5.82 | $24.1K | 74,318 |
| Feb 18, 2026↗ | Herzich Paul | officer: Chief Technology Officer | Sell | 3,616 | $5.82 | $21.1K | 72,638 |
| Feb 18, 2026↗ | Howton David T | officer: Chief Operating Officer | Sell | 7,469 | $5.82 | $43.5K | 105,077 |
| Feb 18, 2026↗ | Tan Kevin | officer: CFO & Treasurer | Sell | 10,808 | $5.82 | $62.9K | 99,422 |
| Feb 13, 2026↗ | Cumbo Alexander | President and CEO | Sell | 16,644 | $5.82 | $96.9K | 0 |
| Feb 13, 2026↗ | Ganot Ilan | Director | Sell | 2,658 | $5.82 | $15.5K | 0 |
| Feb 13, 2026↗ | Hanrahan Jessie | Chief Regulatory Officer | Sell | 4,134 | $5.82 | $24.1K | 0 |
| Feb 13, 2026↗ | Herzich Paul | Chief Technology Officer | Sell | 3,616 | $5.82 | $21.1K | 0 |
| Feb 13, 2026↗ | Howton David T | Chief Operating Officer | Sell | 7,469 | $5.82 | $43.5K | 0 |
| Feb 6, 2026↗ | Brooks Gabriel | officer: Chief Medical Officer | Sell | 12,616 | $6.44 | $81.3K | 84,092 |
| Feb 6, 2026↗ | Cumbo Alexander | director, officer: President and CEO | Sell | 48,913 | $6.44 | $315.1K | 222,018 |
| Feb 6, 2026↗ | Ganot Ilan | director | Sell | 7,205 | $6.44 | $46.4K | 25,271 |
| Feb 6, 2026↗ | Hanrahan Jessie | officer: Chief Regulatory Officer | Sell | 12,348 | $6.44 | $79.5K | 70,327 |
| Feb 6, 2026↗ | Herzich Paul | officer: Chief Technology Officer | Sell | 10,905 | $6.44 | $70.2K | 69,067 |
| Feb 6, 2026↗ | Howton David T | officer: Chief Operating Officer | Sell | 18,894 | $6.44 | $121.7K | 97,859 |
| Feb 6, 2026↗ | Tan Kevin | officer: CFO & Treasurer | Sell | 14,783 | $6.44 | $95.2K | 94,201 |
| Feb 2, 2026↗ | Brooks Gabriel | officer: Chief Medical Officer | Sell | 28,335 | $6.44 | $182.4K | 96,708 |
| Feb 2, 2026↗ | Cumbo Alexander | director, officer: President and CEO | Sell | 80,258 | $6.44 | $516.6K | 270,931 |
| Feb 2, 2026↗ | Hanrahan Jessie | officer: Chief Regulatory Officer | Sell | 26,535 | $6.44 | $170.8K | 82,675 |
| Feb 2, 2026↗ | Herzich Paul | officer: Chief Technology Officer | Sell | 26,250 | $6.44 | $169.0K | 79,972 |
| Feb 2, 2026↗ | Howton David T | officer: Chief Operating Officer | Sell | 37,771 | $6.44 | $243.1K | 116,753 |
| Feb 2, 2026↗ | Tan Kevin | officer: CFO & Treasurer | Sell | 26,837 | $6.44 | $172.7K | 108,984 |
| Jan 30, 2026↗ | Ganot Ilan | director | Sell | 191 | $6.59 | $1.3K | 17,476 |
| Jan 13, 2026↗ | Tan Kevin | officer: CFO & Treasurer | Sell | 5,704 | $5.27 | $30.1K | 46,100 |
| Jan 6, 2026↗ | Ganot Ilan | director | Sell | 1,053 | $5.43 | $5.7K | 17,278 |
| Dec 4, 2025↗ | Cumbo Alexander | President and CEO | Sell | 10,808 | $5.11 | $55.2K | 81,388 |
| Dec 4, 2025↗ | Hanrahan Jessie | Chief Regulatory Officer | Sell | 4,483 | $5.11 | $22.9K | 26,660 |
| Dec 4, 2025↗ | Herzich Paul | Chief Technology Officer | Sell | 2,701 | $5.11 | $13.8K | 26,622 |
| Dec 4, 2025↗ | Howton David T | Chief Operating Officer | Sell | 4,932 | $5.11 | $25.2K | 32,908 |
| Nov 13, 2025↗ | Ganot Ilan | Sell | 3,278 | $4.12 | $13.5K | 95,412 | |
| Oct 21, 2025↗ | Brooks Gabriel | Chief Medical Officer | Sell | 2,895 | $5.96 | $17.3K | 33,819 |
| Mar 13, 2025↗ | Kahn Clare | Buy | 1,860 | $5.34 | $9.9K | 2,960 | |
| Feb 21, 2025↗ | Bain Capital Life Sciences Investors, LLC | Buy | 1,000,000 | $4.03 | $4.03M | 5,034,580 | |
| Feb 21, 2025↗ | PERCEPTIVE ADVISORS LLC | Director | Buy | 5,000,000 | $4.03 | $20.15M | 11,833,500 |
| Feb 19, 2025↗ | Adage Capital Management, L.P. | 10% Owner | Buy | 252,545 | $7.56 | $1.91M | 4,248,080 |
| Feb 18, 2025↗ | Brooks Gabriel | Chief Medical Officer | Sell | 3,256 | $3.96 | $12.9K | 22,812 |
| Feb 18, 2025↗ | Cumbo Alexander | President and CEO | Sell | 11,365 | $3.96 | $45.0K | 60,717 |
| Feb 18, 2025↗ | Ganot Ilan | Sell | 1,711 | $3.96 | $6.8K | 14,839 | |
| Feb 18, 2025↗ | Hanrahan Jessie | Chief Regulatory Officer | Sell | 3,079 | $3.96 | $12.2K | 19,281 |
| Feb 18, 2025↗ | Herzich Paul | Chief Technology Officer | Sell | 2,688 | $3.96 | $10.6K | 18,388 |
| Feb 18, 2025↗ | Howton David T | Chief Operating Officer | Sell | 5,561 | $3.96 | $22.0K | 24,789 |
| Feb 18, 2025↗ | Tan Kevin | CFO & Treasurer | Sell | 3,164 | $3.96 | $12.5K | 32,250 |
| Jan 29, 2025↗ | Ganot Ilan | Sell | 144 | $3.11 | $447.78 | 11,689 | |
| Jan 13, 2025↗ | Tan Kevin | CFO & Treasurer | Sell | 4,073 | $3.89 | $15.8K | 24,789 |
| Jan 7, 2025↗ | Ganot Ilan | Sell | 1,056 | $4.31 | $4.6K | 11,445 | |
| Dec 4, 2024↗ | Cumbo Alexander | President and CEO | Sell | 11,114 | $5.60 | $62.2K | 38,484 |
| Dec 4, 2024↗ | Hanrahan Jessie | Chief Regulatory Officer | Sell | 4,610 | $5.60 | $25.8K | 14,235 |
| Dec 4, 2024↗ | Herzich Paul | Chief Technology Officer | Sell | 2,777 | $5.60 | $15.6K | 12,182 |
Showing 1–50 of 74
1 / 2
SLDB Insider Buying Activity
The following table shows recent insider purchases of Solid Biosciences Inc. (SLDB) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Mar 13, 2025↗ | Kahn Clare | Buy | 1,860 | $5.34 | $9.9K | 2,960 | |
| Feb 21, 2025↗ | Bain Capital Life Sciences Investors, LLC | Buy | 1,000,000 | $4.03 | $4.03M | 5,034,580 | |
| Feb 21, 2025↗ | PERCEPTIVE ADVISORS LLC | Director | Buy | 5,000,000 | $4.03 | $20.15M | 11,833,500 |
| Feb 19, 2025↗ | Adage Capital Management, L.P. | 10% Owner | Buy | 252,545 | $7.56 | $1.91M | 4,248,080 |
SLDB Insider Selling Activity
The following table shows recent insider sales of Solid Biosciences Inc. (SLDB) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Feb 18, 2026↗ | Cumbo Alexander | director, officer: President and CEO | Sell | 16,644 | $5.82 | $96.9K | 235,405 |
| Feb 18, 2026↗ | Ganot Ilan | director | Sell | 2,658 | $5.82 | $15.5K | 27,474 |
| Feb 18, 2026↗ | Hanrahan Jessie | officer: Chief Regulatory Officer | Sell | 4,134 | $5.82 | $24.1K | 74,318 |
| Feb 18, 2026↗ | Herzich Paul | officer: Chief Technology Officer | Sell | 3,616 | $5.82 | $21.1K | 72,638 |
| Feb 18, 2026↗ | Howton David T | officer: Chief Operating Officer | Sell | 7,469 | $5.82 | $43.5K | 105,077 |
| Feb 18, 2026↗ | Tan Kevin | officer: CFO & Treasurer | Sell | 10,808 | $5.82 | $62.9K | 99,422 |
| Feb 13, 2026↗ | Cumbo Alexander | President and CEO | Sell | 16,644 | $5.82 | $96.9K | 0 |
| Feb 13, 2026↗ | Ganot Ilan | Director | Sell | 2,658 | $5.82 | $15.5K | 0 |
| Feb 13, 2026↗ | Hanrahan Jessie | Chief Regulatory Officer | Sell | 4,134 | $5.82 | $24.1K | 0 |
| Feb 13, 2026↗ | Herzich Paul | Chief Technology Officer | Sell | 3,616 | $5.82 | $21.1K | 0 |
| Feb 13, 2026↗ | Howton David T | Chief Operating Officer | Sell | 7,469 | $5.82 | $43.5K | 0 |
| Feb 6, 2026↗ | Brooks Gabriel | officer: Chief Medical Officer | Sell | 12,616 | $6.44 | $81.3K | 84,092 |
| Feb 6, 2026↗ | Cumbo Alexander | director, officer: President and CEO | Sell | 48,913 | $6.44 | $315.1K | 222,018 |
| Feb 6, 2026↗ | Ganot Ilan | director | Sell | 7,205 | $6.44 | $46.4K | 25,271 |
| Feb 6, 2026↗ | Hanrahan Jessie | officer: Chief Regulatory Officer | Sell | 12,348 | $6.44 | $79.5K | 70,327 |
| Feb 6, 2026↗ | Herzich Paul | officer: Chief Technology Officer | Sell | 10,905 | $6.44 | $70.2K | 69,067 |
| Feb 6, 2026↗ | Howton David T | officer: Chief Operating Officer | Sell | 18,894 | $6.44 | $121.7K | 97,859 |
| Feb 6, 2026↗ | Tan Kevin | officer: CFO & Treasurer | Sell | 14,783 | $6.44 | $95.2K | 94,201 |
| Feb 2, 2026↗ | Brooks Gabriel | officer: Chief Medical Officer | Sell | 28,335 | $6.44 | $182.4K | 96,708 |
| Feb 2, 2026↗ | Cumbo Alexander | director, officer: President and CEO | Sell | 80,258 | $6.44 | $516.6K | 270,931 |
| Feb 2, 2026↗ | Hanrahan Jessie | officer: Chief Regulatory Officer | Sell | 26,535 | $6.44 | $170.8K | 82,675 |
| Feb 2, 2026↗ | Herzich Paul | officer: Chief Technology Officer | Sell | 26,250 | $6.44 | $169.0K | 79,972 |
| Feb 2, 2026↗ | Howton David T | officer: Chief Operating Officer | Sell | 37,771 | $6.44 | $243.1K | 116,753 |
| Feb 2, 2026↗ | Tan Kevin | officer: CFO & Treasurer | Sell | 26,837 | $6.44 | $172.7K | 108,984 |
| Jan 30, 2026↗ | Ganot Ilan | director | Sell | 191 | $6.59 | $1.3K | 17,476 |
| Jan 13, 2026↗ | Tan Kevin | officer: CFO & Treasurer | Sell | 5,704 | $5.27 | $30.1K | 46,100 |
| Jan 6, 2026↗ | Ganot Ilan | director | Sell | 1,053 | $5.43 | $5.7K | 17,278 |
| Dec 4, 2025↗ | Cumbo Alexander | President and CEO | Sell | 10,808 | $5.11 | $55.2K | 81,388 |
| Dec 4, 2025↗ | Hanrahan Jessie | Chief Regulatory Officer | Sell | 4,483 | $5.11 | $22.9K | 26,660 |
| Dec 4, 2025↗ | Herzich Paul | Chief Technology Officer | Sell | 2,701 | $5.11 | $13.8K | 26,622 |
| Dec 4, 2025↗ | Howton David T | Chief Operating Officer | Sell | 4,932 | $5.11 | $25.2K | 32,908 |
| Nov 13, 2025↗ | Ganot Ilan | Sell | 3,278 | $4.12 | $13.5K | 95,412 | |
| Oct 21, 2025↗ | Brooks Gabriel | Chief Medical Officer | Sell | 2,895 | $5.96 | $17.3K | 33,819 |
| Feb 18, 2025↗ | Brooks Gabriel | Chief Medical Officer | Sell | 3,256 | $3.96 | $12.9K | 22,812 |
| Feb 18, 2025↗ | Cumbo Alexander | President and CEO | Sell | 11,365 | $3.96 | $45.0K | 60,717 |
| Feb 18, 2025↗ | Ganot Ilan | Sell | 1,711 | $3.96 | $6.8K | 14,839 | |
| Feb 18, 2025↗ | Hanrahan Jessie | Chief Regulatory Officer | Sell | 3,079 | $3.96 | $12.2K | 19,281 |
| Feb 18, 2025↗ | Herzich Paul | Chief Technology Officer | Sell | 2,688 | $3.96 | $10.6K | 18,388 |
| Feb 18, 2025↗ | Howton David T | Chief Operating Officer | Sell | 5,561 | $3.96 | $22.0K | 24,789 |
| Feb 18, 2025↗ | Tan Kevin | CFO & Treasurer | Sell | 3,164 | $3.96 | $12.5K | 32,250 |
| Jan 29, 2025↗ | Ganot Ilan | Sell | 144 | $3.11 | $447.78 | 11,689 | |
| Jan 13, 2025↗ | Tan Kevin | CFO & Treasurer | Sell | 4,073 | $3.89 | $15.8K | 24,789 |
| Jan 7, 2025↗ | Ganot Ilan | Sell | 1,056 | $4.31 | $4.6K | 11,445 | |
| Dec 4, 2024↗ | Cumbo Alexander | President and CEO | Sell | 11,114 | $5.60 | $62.2K | 38,484 |
| Dec 4, 2024↗ | Hanrahan Jessie | Chief Regulatory Officer | Sell | 4,610 | $5.60 | $25.8K | 14,235 |
| Dec 4, 2024↗ | Herzich Paul | Chief Technology Officer | Sell | 2,777 | $5.60 | $15.6K | 12,182 |
SLDB Insiders
Similar Stocks to SLDB
VRTX
Vertex Pharmaceuticals Incorporated
$470.20-1.66%
$121.44B
REGN
Regeneron Pharmaceuticals, Inc.
$743.51-0.41%
$77.57B
ALNY
Alnylam Pharmaceuticals, Inc.
$313.45-1.19%
$42.07B
INSM
Insmed Incorporated
$139.06-0.33%
$30.07B
UTHR
United Therapeutics Corporation
$536.12+0.97%
$23.50B
MRNA
Moderna, Inc.
$52.56-1.89%
$20.76B
ROIV
Roivant Sciences Ltd.
$28.06-1.44%
$20.08B
RPRX
Royalty Pharma plc
$45.65-0.57%
$19.56B